Scholars Central

Conference abstract

Therapeutic effects of the collagen-binding motif as a novel osteoporosis medication in cerebral palsy with bone loss

Authors: Yoon Kyum Shin, Ji Hea Yu, Jung Hwa Seo, Soohyun Wi, MinGi Kim, Ahreum Baek, Suk Young Song, Bae Geun Nam, Soonil Pyo, Eunju Cho, Sung Rae Cho

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cerebral palsy (CP) is a static lesion occurring in the immature brain from multifactorial causes including hypoxicischemia, resulting a life long motor impairment. Of note, severe patients with CP suffer from bone loss due to prolonged conditions of limited weight bearing in adulthood. In the transcriptome analysis, osteopontin (SPP1) gene expression in the peripheral blood mononuclear cells was significantly down regulated in adults with CP (n=13) than healthy adults. (n=13; fold change=-70.10). The osteopontin has multifaceted function of biomineralization by involving bone resorption and formation. A novel collagen binding motif (CBM) of osteopontin, is recently identified to induce bone formation via facilitating osteogenesis and inhibiting adipogenesis. We aim to propose reasonable therapeutic evidences for patients with CP who have osteopenia or osteoporosis by applying a novel osteoporosis medication in an animal model of neonatal hypoxic-ischemic (HI) brain injury. 7-day-old CD-1 pup mice underwent ischemic brain injury induced by unilateral right common carotid artery ligation and induced hypoxic condition. Severe HI brain injured mice were included to CBM administration for eight weeks. In the bone geometrical analysis, bone surface density and trabecular number were significantly increased after long term administration of CBM, while trabecular separation was significantly reduced compared to saline control. Through enzyme linked immunosorbent assay, we identified bone turnover markers including C - terminal telopeptide and procollagen type I were highly regulated in CBM treatment group compared to saline control. In an animal model of neonatal hypoxic-ischemic (HI) brain injury, the CBM improved bone geometrical components and bone turn over activity. This clinically translational investigation using the CBM shed lights on therapeutic administration for bone loss in adults with CP.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBrain Disorders & Therapy
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Yoon Kyum Shin”
  • BylineArticles whose byline prints “Ji Hea Yu”
  • BylineArticles whose byline prints “Jung Hwa Seo”
  • BylineArticles whose byline prints “Soohyun Wi”
  • BylineArticles whose byline prints “MinGi Kim”
  • BylineArticles whose byline prints “Ahreum Baek”
  • BylineArticles whose byline prints “Suk Young Song”
  • BylineArticles whose byline prints “Bae Geun Nam”